Vertex to Present at Cowen’s 42nd Annual Health Care Conference on March 8

Rhea-AI Summary

Vertex Pharmaceuticals (NASDAQ: VRTX) announced management's presentation at Cowen’s 42nd Annual Health Care Conference on March 8, 2022, at 2:50 p.m. ET. A live webcast will be available on their website, with a replay archived thereafter. Vertex is a global biotechnology firm focused on innovative medicines for serious diseases, particularly cystic fibrosis. The company, founded in 1989 and headquartered in Boston, has a strong pipeline targeting conditions like sickle cell disease and type 1 diabetes.

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at Cowen’s 42nd Annual Health Care Conference on Tuesday, March 8, 2022 at 2:50 p.m. ET.

A live webcast of management's remarks will be available through Vertex's website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website.

About Vertex

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and has several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule, cell and genetic therapies in other serious diseases where it has deep insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, pain, type 1 diabetes, alpha-1 antitrypsin deficiency and Duchenne muscular dystrophy.

Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston's Innovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 12 consecutive years on Science magazine's Top Employers list and one of the 2021 Seramount (formerly Working Mother Media) 100 Best Companies. For company updates and to learn more about Vertex's history of innovation, visit www.vrtx.com or follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

(VRTX-WEB)

View source version on businesswire.com: https://www.businesswire.com/news/home/20220301006167/en/

Vertex Pharmaceuticals Incorporated Investors:

Michael Partridge, 617-341-6108

Manisha Pai, 617-429-6891

Miroslava Minkova, 617-341-6135

Source: Vertex Pharmaceuticals Incorporated

FAQ

When will Vertex Pharmaceuticals present at Cowen’s 42nd Annual Health Care Conference?

Vertex Pharmaceuticals will present on March 8, 2022, at 2:50 p.m. ET.

How can I watch Vertex Pharmaceuticals' presentation at the Cowen conference?

A live webcast of Vertex Pharmaceuticals' presentation will be available on their website.

What is Vertex Pharmaceuticals' stock symbol?

Vertex Pharmaceuticals' stock symbol is VRTX.

What diseases does Vertex Pharmaceuticals focus on?

Vertex Pharmaceuticals focuses on diseases like cystic fibrosis, sickle cell disease, and type 1 diabetes.

Where is Vertex Pharmaceuticals headquartered?

Vertex Pharmaceuticals is headquartered in Boston.